glucotrack.com (GCTK): Market Cap to Revenue

Symbol and logo of brand GlucoTrack Inc. (GCTK)

High investor expectations for GlucoTrack, Inc. (GCTK) innovations have triggered a sharp spike in the price-to-sales ratio. This growth is supported by the development of ultrasonic sensors and software; however, success depends on FDA approval and device accuracy. Analysis of the price action reflects that the current value is , which necessitates caution when determining the entry point into the asset.

GCTK GlucoTrack Inc. P/S Multiple (07/04/2022 - 11/13/2026)

Analytical breakdowns for GlucoTrack, Inc. (GCTK)

- share price and consensus valuation forecast:
Price Performance Chart GlucoTrack Inc.|GCTK - Price Target Chart
- stock exchange capitalization data:
Market Valuation GlucoTrack|GCTK - Enterprise Value
- book value of equity indicators:
Net Asset Value per Share GlucoTrack|GCTK - Book Capitalization|Capitalization to Book Value Ratio glucotrack.com|GCTK - Company Total Assets
- debt obligations and liquidity statistics:
Total Debt to Capital Coefficient GlucoTrack, Inc.|GCTK - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio glucotrack.com|GCTK - Company Aggregate Debts|Debts to Book Capitalization GlucoTrack|GCTK - Company Long-Term Debt|Company Short-Term Debt GlucoTrack|Intermediate Coverage Ratio glucotrack.com
- earnings and multiples data:
GCTK - Net Profit|Expected Net Profit GlucoTrack, Inc.|GCTK - Price to Earnings Ratio|Forward Price to Earnings Multiple GlucoTrack Inc.|GCTK - Price/Earnings to Growth Multiple|EV/EBITDA Multiple GlucoTrack|GCTK - Operating profit EBITDA|Net earnings per share for the last four quarters GlucoTrack|GCTK - Earnings per share for the last twelve months|Year-over-year net earnings per share trend for the last twelve months glucotrack.com|GCTK - Earnings per share growth in current year|Expected earnings per share growth for next year GlucoTrack, Inc.
- issuer revenue and sales details:
GCTK - Revenue and Sales Volume|Company Expected Sales Volume glucotrack.com|GCTK - Price-to-Revenue Ratio|Market Cap to Projected Revenue GlucoTrack
General company analysis:GCTK GlucoTrack Inc.
Core merchandise of GlucoTrack

Conservative capital demands maximum transparency in business valuation relative to operating income to avoid overpayment. This indicator measures market capitalization through the lens of generated revenue, allowing for the real-time tracking of the fundamental value of GlucoTrack, Inc. (GCTK) without time lags. Stable demand for essential medical supplies minimizes geopolitical risks, making the company's P/S ratio a reliable tool for analyzing business resilience.

Competitors of GlucoTrack, Inc.

DXCM (dexcom.com) - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio Penumbra PEN|NOVT - Market Cap to Revenue|Haemonetics Corp. - P/S Multiple|Price to Sales Inspire Medical Systems Inc|PRCT: P/S Multiple|Market Cap to Revenue Ratio CNMD|PLSE (Pulse Biosciences) - P/S Multiple|InMode Ltd (INMD) - Price-to-Revenue Coefficient|P/S Multiple PMI|Market Cap to Revenue Surmodics Inc. SRDX|P/S Multiple SENS (Senseonics Holdings)|P/S Multiple neuropace.com NPCE|TCMD - Price-to-Revenue Ratio|SNWV: Price-to-Revenue Ratio|OM (Outset) - Market Cap to Revenue|Electromed - Market Capitalization-to-Revenue Ratio|LNSR (LENSAR, Inc.) - P/S Multiple|Price to Sales avitamedical.com RCEL|Price-to-Revenue Ratio Profound Medical Corp. (PROF)|bairdmed.com (BDMD) - Price-to-Revenue Multiple|EDAP TMS - Market Cap to Revenue|P/S Multiple Apyx Medical Corp APYX|IceCure Medical, Ltd. - P/S Multiple|Price-to-Revenue Coefficient Pulmonx Corporation LUNG|telabio.com (TELA) - Price-to-Revenue Ratio|Price-to-Sales Ratio CTSO (CytoSorbents Corporation)|Price-to-Revenue Ratio Sensus Healthcare Corp|Market Cap to Revenue Zynex Corp (ZYXI)|P/S Multiple ECOR|RBOT - Price to Sales|Price-to-Revenue Ratio Inspira Technologies IINN|ICU: Market Cap to Revenue Ratio|IRIX: Market Cap to Revenue|Intelligent Bio Solutions - Market Cap to Sales Volume|XAIR: P/S Multiple|Price-to-Revenue Multiple profusa.com PFSA|Price-to-Revenue Ratio STRATA Skin Sciences Inc.|Price-to-Revenue Ratio NAOV|Market Cap to Revenue VERO (Venus Concept Corp)|P/S Multiple Nuwellis Corp (NUWE)|P/S Multiple AEMD (Aethlon Medical)|ASXC - Market Cap to Revenue|AVGR - Price-to-Revenue Ratio|Price to Sales BioSig|CUTR (Cutera, Inc) - Market Cap to Revenue|KNW: Market Cap to Sales Volume|Price-to-Revenue Ratio Inari Medical, Inc.|NVRO: Market Capitalization-to-Revenue Ratio|P/S Multiple RSLS|P/S Multiple Silk Road Medical, Inc. (SILK)